Journal
FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.686271
Keywords
desensitization; sensitization; kidney transplantation; donor specific antibody (DSA); crossmatch; single antigen bead assays (SAB); antibody mediated rejection; kidney paired donation
Categories
Ask authors/readers for more resources
Significant advancements have been made in HLA antibody detection techniques and understanding outcomes of solid organ transplant in the presence of HLA antibody over the past 50 years. Kidney paired donation programs have become widespread, deceased donor allocation policies have changed, and new therapeutic options show promise in reducing HLA antibody production.
Major advancements in the development of HLA antibody detection techniques and our understanding of the outcomes of solid organ transplant in the context of HLA antibody have occurred since the relevance of sensitization was first recognized nearly 50 years ago. Additionally, kidney paired donation programs (KPD) have become widespread, deceased donor allocation policies have changed, and several new therapeutic options have become available with promise to reduce HLA antibody. In this overview we aim to provide thoughtful guidance about when desensitization in kidney transplantation should be considered taking into account the outcomes of HLA incompatible transplantation. Novel therapeutics, desensitization endpoints, and strategies for future study will also be discussed. While most of our understanding about desensitization comes from studying kidney transplant candidates and recipients, many of the concepts discussed can be easily applied to desensitization in all of solid organ transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available